Determination of the significance of in vitro blast cell [3H]thymidine labelling indices obtained initially and serially during induction therapy of acute non-lymphocytic leukemia.

[1]  W. W. Daniel.  Applied Nonparametric Statistics , 1978 .

[2]  E. Gehan,et al.  Therapy of acute myelogenous leukemia , 1978 .

[3]  G. Humphrey,et al.  Remission induction in acute myelogenous leukemia using cytosine arabinoside synchronization: a Southwest Oncology Group Study. , 1978, Medical and pediatric oncology.

[4]  R. Camplejohn,et al.  Assessment of inherent fluctuations of mitotic and labelling indices of human tumours. , 1977, British Journal of Cancer.

[5]  H. Preisler,et al.  Separation of leukemic cells into proliferative and quiescent subpopulations by centrifugal elutriation. , 1977, Cancer research.

[6]  S. George,et al.  Prognostic significance of pretreatment proliferative activity in adult acute leukemia , 1977 .

[7]  M. Baccarani,et al.  Cell flux studies during chemotherapy with multiple doses of arabinosyl cytosine in chronic myeloid leukemia , 1977 .

[8]  P. Nilsson,et al.  Prognostic implications of chromosome analysis in acute non-lymphocytic leukemia , 1977 .

[9]  M. Baccarani,et al.  Arabinosyl cytosine in chronic myeloid leukaemia: evidence for high cytokinetic sensitivity of myeloblasts. , 2009, Scandinavian journal of haematology.

[10]  B. Barlogie,et al.  Age-dependent survival and cell-cycle progression of cultured cells exposed to chemotherapeutic drugs. , 1976, Cancer treatment reports.

[11]  B. Barlogie,et al.  A simplified in vitro classification for prognosis in adult acute leukemia: the application of in vitro results in remission-predictive models. , 1976, Blood.

[12]  H. Keizer,et al.  Synchronization in tumour chemotherapy. , 1976, European journal of cancer.

[13]  B. Lampkin,et al.  Manipulation of the Mitotic Cycle in the Treatment of Acute Myelogenous Leukaemia , 1976, British journal of haematology.

[14]  D. Crowther,et al.  Factors influencing prognosis in adults with acute myelogenous leukaemia. , 1975, British Journal of Cancer.

[15]  L. V. van Putten,et al.  Proliferation-dependent cytotoxicity of anticancer agents: a review. , 1975, Cancer research.

[16]  S. Perry,et al.  Cytokinetics of human acute leukemia before and after chemotherapy. , 1975, European journal of cancer.

[17]  C. Haanen,et al.  BONE-MARROW-PROLIFERATION PATTERNS IN ACUTE MYELOBLASTIC LEUKAMIA DETERMINED BY PULSE CYTOPHOTOMETRY , 1975, The Lancet.

[18]  R. Zittoun,et al.  Prediction of the response to chemotherapy in acute leukemia , 1975, Cancer.

[19]  A. Sandberg,et al.  Chromosomes and causation of human cancer and leukemia. IX. Prognostic and therapeutic value of chromosomal findings in acute myeloblastic leukemia , 1974, Cancer.

[20]  K. Ho,et al.  Chemotherapy after synchronization of tumor cells. , 1974 .

[21]  D. Groth,et al.  Correlation of cytosine arabinoside‐induced increment in growth fraction of leukemic blast cells with clinical response , 1974, Cancer.

[22]  A. Faille,et al.  Perturbation of cell cycle of human leukaemic myeloblasts in vivo by cytosine arabinoside. , 2009, Scandinavian journal of haematology.

[23]  Chumakova My,et al.  Schedule dependence of the lethal effects of 6-azauridine and cytosine arabinoside on murine leukemia cells (L5178Y) in culture , 1973 .

[24]  F. Lachapelle,et al.  Mode of action of chemotherapy in vivo on human acute leukemia. I. Daunomycin. , 1973, The Journal of clinical investigation.

[25]  H. Crissman,et al.  Use of flow microfluorometry in detailed analysis of effects of chemical agents on cell cycle progression. , 1972, Cancer research.

[26]  D. Cox.  Regression Models and Life-Tables , 1972 .

[27]  M. Zelen,et al.  Effect of length sampling bias on labeled mitotic index waves. , 1971, Journal of Theoretical Biology.

[28]  D. Cox,et al.  The analysis of binary data , 1971 .

[29]  A. Pileri,et al.  Proliferative Potential of Out-of-cycle Leukaemic Cells , 1969, Nature.

[30]  D. Cox,et al.  The statistical analysis of series of events , 1966 .

[31]  H. Fallon,et al.  Summary of current information on 6-azauridine. , 1962, Cancer chemotherapy reports.

[32]  H. Levene.  Robust tests for equality of variances , 1961 .

[33]  Oscar Kempthorne,et al.  The Design and Analysis of Experiments , 1952 .